Below are details on the various committees, processes, and documents that govern the working of the Genomics England Clinical Interpretation Partnership (GeCIP).

Committees

GeCIP Board

Chair: Professor Dame Kay Davies

The GeCIP Board is tasked with overseeing and steering GeCIP. It is comprised of:

• representatives from funders (National Institute for Health Research, Wellcome Trust, Medical Research Council, Cancer Research UK);
• a representative from the Genomics England Scientific Advisory Committee;
• the Genomics England Chief Scientist, Prof Mark Caulfield;
• a patient representative;
• and a representative from each of the Cancer, Rare Diseases, and Cross-Cutting arms of GeCIP, as decided by the GeCIP Steering Committee.

>>Visit the GeCIP Board page with meeting membership details and meeting minutes

GeCIP Steering Committee

Access Review Committee

Scientific Advisory Committee

Cancer Working Group

Rare Diseases Working Group

Cross-Cutting Working Group